Beta Bionics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
45.0M
on 2026-06-30, from 6.67M on 2024-12-31 10-Q ↗
a raise that quarter, at its price
Newest
No limit
S-3ASR of 2026-02-24. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since. S-3ASR ↗
None
No at-the-market programme on file in the last 30 months.
Cash
12.9 quarters
$180.5M on 2026-06-30 ÷ $14.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-17 | Public offering incl. 1.04M pre-funded | 8,695,659 | $17.25 | $150.0M | 424B5 ↗ |
| 2025-01-21 | Private placement | 1,000,000 | $17.00 | not stated | 8-K ↗ |